Is Ambrx Biopharma Inc (AMAM) Stock a Bad Value Tuesday?

Tuesday, October 24, 2023 12:31 PM | InvestorsObserver Analysts

Mentioned in this article

Is Ambrx Biopharma Inc (AMAM) Stock a Bad Value Tuesday?

The 38 rating InvestorsObserver gives to Ambrx Biopharma Inc (AMAM) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 78 percent of stocks in the Healthcare sector, AMAM’s 38 overall rating means the stock scores better than 38 of all stocks.

AMAM has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on AMAM!

See Full AMAM Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Ambrx Biopharma Inc Stock Today?

Ambrx Biopharma Inc (AMAM) stock is trading at $10.41 as of 12:21 PM on Tuesday, Oct 24, a gain of $2.01, or 23.87% from the previous closing price of $8.40. The stock has traded between $8.23 and $10.80 so far today. Volume today is low. So far 763,976 shares have traded compared to average volume of 1,297,970 shares. Click Here to get the full Stock Report for Ambrx Biopharma Inc stock.